---
title: "Cargo Therapeutics (CRGX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CRGX.US.md"
symbol: "CRGX.US"
name: "Cargo Therapeutics"
industry: "Biotechnology"
---

# Cargo Therapeutics (CRGX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |

## Company Profile

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States. The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumo...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.97 | 215/603 | - | - | - |
| PB | 0.91 | 99/603 | 0.91 | 0.91 | 0.59 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.47 |

## References

- [Company Overview](https://longbridge.com/en/quote/CRGX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CRGX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CRGX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.